{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:33:52Z","timestamp":1785803632049,"version":"3.56.0"},"reference-count":34,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,1,15]]},"abstract":"<jats:p>Platelets play an important role in hemostasis, with inappropriate platelet activation being a major contributor to debilitating and often fatal thrombosis by causing myocardial infarction and stroke. Although current antithrombotic treatment is generally well tolerated and effective, many patients still experience cardiovascular problems, which may reflect the existence of alternative underlying regulatory mechanisms in platelets to those targeted by existing drugs. In this study, we define a role for peripherally distributed members of the tachykinin family of peptides, namely substance P and the newly discovered endokinins A and B that are present in platelets, in the activation of platelet function and thrombus formation. We have reported previously that the preferred pharmacologically characterized receptor for these peptides, the NK1 receptor, is present on platelets. Inhibition or deficiency of the NK1 receptor, or SP agonist activity, resulted in substantially reduced thrombus formation in vitro under arterial flow conditions, increased bleeding time in mice, and a decrease in experimentally induced thromboembolism. Inhibition of the NK1 receptor may therefore provide benefit in patients vulnerable to thrombosis and may offer an alternative therapeutic target.<\/jats:p>","DOI":"10.1182\/blood-2007-07-103424","type":"journal-article","created":{"date-parts":[[2007,9,25]],"date-time":"2007-09-25T22:38:05Z","timestamp":1190759885000},"page":"605-612","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":38,"title":["Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation"],"prefix":"10.1182","volume":"111","author":[{"given":"Sarah","family":"Jones","sequence":"first","affiliation":[{"name":"School of Biological Sciences, University of Reading, Reading, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Tucker","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Reading, Reading, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Sage","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Reading, Reading, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Kaiser","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Reading, Reading, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha E.","family":"Barrett","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Reading, Reading, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Lowry","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Reading, Reading, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zimmer","sequence":"additional","affiliation":[{"name":"Institute of Molecular Psychiatry, Life & Brain Centre, University of Bonn, Bonn, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Hunt","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Developmental Biology, University College London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Emerson","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Gibbins","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Reading, Reading, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111813142120000_B1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1055\/s-0038-1657598","article-title":"Mechanisms initiating platelet thrombus formation.","volume":"78","author":"Ruggeri","year":"1997","journal-title":"Thromb Haemost"},{"key":"2019111813142120000_B2","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1242\/jcs.01325","article-title":"Adhesion receptor signalling and the regulation of thrombus formation.","volume":"117","author":"Gibbins","year":"2004","journal-title":"J Cell Sci"},{"key":"2019111813142120000_B3","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood.V91.8.2645.2645_2645_2657","article-title":"Integrin signaling: the platelet paradigm.","volume":"91","author":"Shattil","year":"1998","journal-title":"Blood"},{"key":"2019111813142120000_B4","first-page":"3","article-title":"Signaling receptors on platelets and megakaryocyte.","volume":"273","author":"Woulfe","year":"2004","journal-title":"Methods Mol Biol"},{"key":"2019111813142120000_B5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/84667","article-title":"Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis.","volume":"7","author":"Angelillo-Scherrer","year":"2001","journal-title":"Nat Med"},{"key":"2019111813142120000_B6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nm0302-247","article-title":"CD40L stabilizes arterial thrombi by a beta3 integrin\u2013dependent mechanism.","volume":"8","author":"Andre","year":"2002","journal-title":"Nat Med"},{"key":"2019111813142120000_B7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1182\/blood-2004-10-4092","article-title":"Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A.","volume":"106","author":"Kashiwagi","year":"2005","journal-title":"Blood"},{"key":"2019111813142120000_B8","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.0606344104","article-title":"Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury.","volume":"104","author":"Zhu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111813142120000_B9","doi-asserted-by":"crossref","first-page":"9219","DOI":"10.1073\/pnas.142053899","article-title":"Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred.","volume":"99","author":"Prevost","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111813142120000_B10","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1182\/blood-2003-11-3979","article-title":"Tachykinins regulate the function of platelets.","volume":"104","author":"Graham","year":"2004","journal-title":"Blood"},{"key":"2019111813142120000_B11","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1073\/pnas.0931458100","article-title":"Characterization of the endokinins: human tachykinins with cardiovascular activity.","volume":"100","author":"Page","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111813142120000_B12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/35015579","article-title":"Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia.","volume":"405","author":"Page","year":"2000","journal-title":"Nature"},{"key":"2019111813142120000_B13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000203593","article-title":"Hematopoietic modulation by the tachykinins.","volume":"98","author":"Rameshwar","year":"1997","journal-title":"Acta Haematol"},{"key":"2019111813142120000_B14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/pr.54.2.285","article-title":"The tachykinin peptide family.","volume":"54","author":"Severini","year":"2002","journal-title":"Pharmacol Rev"},{"key":"2019111813142120000_B15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/80826","article-title":"Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis.","volume":"1","author":"Zhang","year":"2000","journal-title":"Nat Immunol"},{"key":"2019111813142120000_B16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0378-1119(02)00861-2","article-title":"Identification, localization and receptor characterization of novel mammalian substance P-like peptides.","volume":"296","author":"Kurtz","year":"2002","journal-title":"Gene"},{"key":"2019111813142120000_B17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/32904","article-title":"Altered nociception, analgesia and aggression in mice lacking the receptor for substance P.","volume":"392","author":"De Felipe","year":"1998","journal-title":"Nature"},{"key":"2019111813142120000_B18","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1073\/pnas.95.5.2630","article-title":"Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene.","volume":"95","author":"Zimmer","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111813142120000_B19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2004-02-0608","article-title":"A role for the thiol isomerase ERP5 in platelet function.","volume":"105","author":"Jordan","year":"2005","journal-title":"Blood"},{"key":"2019111813142120000_B20","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood.V89.4.1235","article-title":"A collagen-like peptide stimulates tyrosine phosphorylation of syk and phospholipase C gamma2 in platelets independent of the integrin alpha2beta1.","volume":"89","author":"Asselin","year":"1997","journal-title":"Blood"},{"key":"2019111813142120000_B21","doi-asserted-by":"crossref","first-page":"18095","DOI":"10.1074\/jbc.271.30.18095","article-title":"Tyrosine phosphorylation of the Fc receptor gamma-chain in collagen-stimulated platelets.","volume":"271","author":"Gibbins","year":"1996","journal-title":"J Biol Chem"},{"key":"2019111813142120000_B22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood.V99.1.137","article-title":"Platelet endothelial cell adhesion molecule-1 signaling inhibits the activation of human platelets.","volume":"99","author":"Cicmil","year":"2002","journal-title":"Blood"},{"key":"2019111813142120000_B23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1042\/bj2040847","article-title":"Localization of cyclo-oxygenase and thromboxane synthetase in human-platelet intracellular membranes.","volume":"204","author":"Carey","year":"1982","journal-title":"Biochem J"},{"key":"2019111813142120000_B24","doi-asserted-by":"crossref","first-page":"25885","DOI":"10.1074\/jbc.270.43.25885","article-title":"Cytosolic phospholipase A2 is phosphorylated in collagen- and thrombin-stimulated human platelets independent of protin kinase C and mitogen-activated protein kinase.","volume":"270","author":"Borsch-Haubold","year":"1995","journal-title":"J Biol Chem"},{"key":"2019111813142120000_B25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1042\/bj2590315","article-title":"The eicosanoids and their biochemical-mechanisms of action.","volume":"259","author":"Smith","year":"1989","journal-title":"Biochem J"},{"key":"2019111813142120000_B26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1515\/BC.2000.051","article-title":"The role of heterotrimeric G proteins in platelet activation.","volume":"381","author":"Offermanns","year":"2000","journal-title":"Biol Chem"},{"key":"2019111813142120000_B27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/emm.2004.30","article-title":"Involvement of thromboxane A2 and tyrosine kinase in the synergistic interaction of platelet activating factor and calcium ionophore A23187 in human platelet aggregation.","volume":"36","author":"Rasheed","year":"2004","journal-title":"Exp Mol Med"},{"key":"2019111813142120000_B28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/1357-2725(96)00017-9","article-title":"Tachykinins: Receptor to effector.","volume":"28","author":"Khawaja","year":"1996","journal-title":"Int J Biochem Cell Biol"},{"key":"2019111813142120000_B29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1474-8673.1993.tb00396.x","article-title":"Tachykinin receptors and tachykinin receptor antagonists.","volume":"13","author":"Maggi","year":"1993","journal-title":"J Auton Pharmacol"},{"key":"2019111813142120000_B30","doi-asserted-by":"crossref","first-page":"47438","DOI":"10.1074\/jbc.M408846200","article-title":"A novel G alpha(q\/11)-selective inhibitor.","volume":"279","author":"Takasaki","year":"2004","journal-title":"J Biol Chem"},{"key":"2019111813142120000_B31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7164\/antibiotics.56.358","article-title":"YM-254890, a novel platelet aggregation inhibitor produced by Chromobacterium sp QS3666.","volume":"56","author":"Taniguchi","year":"2003","journal-title":"J Antibiot"},{"key":"2019111813142120000_B32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(96)00706-6","article-title":"L-733,060, a novel tachykinin NK1 receptor antagonist; Effects in [Ca2+](i) mobilisation, cardiovascular and dural extravasation assays.","volume":"317","author":"Seabrook","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"2019111813142120000_B33","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1126\/science.273.5282.1722","article-title":"Neurogenic amplification of immune complex inflammation.","volume":"273","author":"Bozic","year":"1996","journal-title":"Science"},{"key":"2019111813142120000_B34","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1073\/pnas.95.14.8070","article-title":"Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation.","volume":"95","author":"Jin","year":"1998","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/2\/605\/1221075\/zh800208000605.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/2\/605\/1221075\/zh800208000605.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T13:37:29Z","timestamp":1574084249000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/111\/2\/605\/103774\/Peripheral-tachykinins-and-the-neurokinin-receptor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,15]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,1,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-07-103424","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,15]]}}}